Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer

Background: In recent years, great improvement has been made in immunotherapies for non-small cell lung cancer (NSCLC). Current data have suggested that Programmed cell death ligand 1 (PD-L1) expression might not be an ideal marker for patient selection in isolation. Evidence has been increasing tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyue, Cao, Lianjing, Li, Shouying, Wang, Fan, Huang, Dingzhi, Jiang, Richeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856879/
https://www.ncbi.nlm.nih.gov/pubmed/31777599
http://dx.doi.org/10.7150/jca.34469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856879/
https://www.ncbi.nlm.nih.gov/pubmed/31777599
http://dx.doi.org/10.7150/jca.34469

Ejemplares similares